The Novel Angiotensin II Receptor Blocker Azilsartan Medoxomil Ameliorates Insulin Resistance Induced by Chronic Angiotensin II Treatment in Rat Skeletal Muscle

Publisher： Karger

E-ISSN： 1664-5502|3|2|154-164

ISSN： 1664-3828

Source： Cardiorenal Medicine, Vol.3, Iss.2, 2013-06, pp. : 154-164

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Renoprotective Effect of Angiotensin II Receptor Antagonists in Experimental Chronic Renal Failure

By  

American Journal of Nephrology, Vol. 21, Iss. 1, 2001-03 ,pp. : 78-83

Karger

Access to resources Recommend Favorite

Renal and Vascular Injury Induced by Exogenous Angiotensin II Is AT1 Receptor-Dependent

By  

Nephron, Vol. 87, Iss. 1, 2001-01 ,pp. : 66-74

Karger

Access to resources Recommend Favorite

Effects of an Angiotensin II Receptor Antagonist and Angiotensin-Converting Enzyme Inhibitors on Burst Forming Units-Erythroid in Chronic Hemodialysis Patients

By  

American Journal of Nephrology, Vol. 23, Iss. 5, 2003-09 ,pp. : 287-293

Karger

Access to resources Recommend Favorite

Direct Renin Inhibitor is Better than Angiotensin II Receptor Blocker for Intrarenal Arterioles

By  

Kidney and Blood Pressure Research, Vol. 41, Iss. 5, 2016-08 ,pp. : 561-569

Karger

Access to resources Recommend Favorite

Effect of Angiotensin II Receptor Blocker on Plasma Levels of TGF-β1 and Interstitial Fibrosis in Hypertensive Kidney Transplant Patients

By  

American Journal of Nephrology, Vol. 23, Iss. 5, 2003-09 ,pp. : 300-306

Karger

Access to resources Recommend Favorite